Suppr超能文献

人孕激素受体A亚型是一种对人孕激素受体B功能具有细胞和启动子特异性的抑制因子。

Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.

作者信息

Vegeto E, Shahbaz M M, Wen D X, Goldman M E, O'Malley B W, McDonnell D P

机构信息

Ligand Pharmaceuticals Inc., San Diego, California 92121.

出版信息

Mol Endocrinol. 1993 Oct;7(10):1244-55. doi: 10.1210/mend.7.10.8264658.

Abstract

Two distinct isoforms of the human progesterone receptor (hPR-A and hPR-B) have been identified previously. They differ only in that hPR-B contains an additional 164 amino acids at the amino terminus. Among various species these two forms arise as a result of either alternate initiation of translation from the same mRNA or by transcription from alternate promoters within the same gene. In order to understand the reason for their existence, we studied the transcriptional capacity of these individual receptors and observed that their activity was influenced strongly by cell and promoter context. More surprising was the observation that in promoter and cell contexts where hPR-A was inactive, it acted as a potent trans-dominant repressor of hPR-B-mediated transcription. This event occurred at substoichiometric concentrations of hPR-A and was hormone dependent. Human PR-A was not a general repressor of ligand-mediated transcription, as it had no effect on vitamin D receptor function. Interestingly, hPR-A but not hPR-B was capable of a similar inhibition of glucocorticoid, androgen, and mineralocorticoid receptor-mediated gene transcription. This suggests a specific role for the hPR-A isoform in this regulatory process. The trans-dominant effects of hPR-A were induced also by the antiprogestins ZK112993 and ZK98299 and a DNA binding defective hPR-A mutant, suggesting that the inhibitory function of hPR-A does not require DNA binding. The dual role of hPR-A as an activator or repressor of transcription defines a potential mechanism by which cells can generate dissimilar responses to a single hormone and provides a molecular explanation for the existence of two distinct forms of the hPR.

摘要

先前已鉴定出人类孕酮受体的两种不同亚型(hPR-A和hPR-B)。它们的区别仅在于hPR-B在氨基末端额外含有164个氨基酸。在不同物种中,这两种形式是由同一mRNA的交替翻译起始或同一基因内交替启动子的转录产生的。为了理解它们存在的原因,我们研究了这些单个受体的转录能力,并观察到它们的活性受到细胞和启动子环境的强烈影响。更令人惊讶的是,在hPR-A无活性的启动子和细胞环境中,它作为hPR-B介导转录的有效反式显性阻遏物发挥作用。这一事件在hPR-A的亚化学计量浓度下发生,且依赖激素。人类PR-A不是配体介导转录的一般阻遏物,因为它对维生素D受体功能没有影响。有趣的是,hPR-A而非hPR-B能够类似地抑制糖皮质激素、雄激素和盐皮质激素受体介导的基因转录。这表明hPR-A亚型在这一调节过程中具有特定作用。hPR-A的反式显性效应也由抗孕激素ZK112993和ZK98299以及DNA结合缺陷型hPR-A突变体诱导,这表明hPR-A的抑制功能不需要DNA结合。hPR-A作为转录激活剂或阻遏物的双重作用定义了一种潜在机制,通过该机制细胞可以对单一激素产生不同的反应,并为hPR两种不同形式的存在提供了分子解释。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验